Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

BioLife Sciences Inc

Healthcare US BLFE

0.0001USD
0.00(0%)

Last update at 2026-06-23T20:00:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00010.0001
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.32M
  • Volume911
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Income before tax - - - -0.00113M -0.05271M
Minority interest - - - - -
Net income - - - -0.00113M -0.05271M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation - - - - -
Ebit - -0.41986M -1.26727M 0.00000M -
Ebitda - - - 0.17M -0.04228M
Depreciation and amortization 0.23M - - 0.17M -
Non operating income net other - - - - -
Operating income - - - - -0.04228M
Other operating expenses - - - - 0.04M
Interest expense - 0.00000M 0.00000M - 0.01M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue - - - - -
Total operating expenses - - - - 0.04M
Cost of revenue - - - - -
Total other income expense net - - - -0.00113M -0.01043M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - -0.45687M -1.26774M - -
Preferred stock and other adjustments - - - - -
Breakdown 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30
Type yearly yearly yearly yearly yearly
Date 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30
Total assets - - 0.00002M 0.00132M 0.01M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab - - 0.00117M 0.22M 0.20M
Total stockholder equity - - -0.00115M -0.22087M -0.18310M
Deferred long term liab - - - - -
Other current liab 0.09M 0.08M 0.00117M - 0.05M
Common stock 0.00571M 0.00554M - 0.35M 0.33M
Capital stock - - - - -
Retained earnings -1.72576M -1.26889M -0.00115M -4.89474M -4.84202M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash - - 0.00002M 0.00132M 0.01M
Cash and equivalents - - - - -
Total current liabilities 1.07M 0.84M 0.00117M 0.16M 0.13M
Current deferred revenue - - - - -
Net debt - - -0.00002M 0.14M 0.13M
Short term debt - - - 0.08M 0.07M
Short long term debt - - - - -
Short long term debt total - - - 0.14M 0.14M
Other stockholder equity -0.00673M -0.03586M - 4.33M 4.66M
Property plant equipment 0.12M 0.20M - - -
Total current assets 0.08M 0.07M 0.00002M 0.00132M 0.01M
Long term investments - - - - -
Net tangible assets -0.88033M -0.68958M - - -
Short term investments - - - - -
Net receivables - - - - -
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.58M 0.49M - 0.08M -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -0.33385M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30
Type yearly yearly yearly yearly yearly
Date 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30
Investments - - - - -
Change to liabilities 0.21M 0.30M - - -
Total cashflows from investing activities - -0.00096M - - -
Net borrowings 0.07M 0.88M - - -
Total cash from financing activities 0.07M 0.99M - 0.00150M 0.03M
Change to operating activities -0.02363M -0.03587M - - -
Net income -0.45687M -1.26774M -0.00113M -0.05271M -0.34039M
Change in cash -0.01766M 0.03M -0.00130M -0.01102M 0.01M
Begin period cash flow - 0.40M 0.00132M 0.01M -
End period cash flow - - 0.00002M 0.00132M 0.01M
Total cash from operating activities -0.10655M -1.00040M 0.00002M -0.01252M -0.01863M
Issuance of capital stock - - - - -
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - 0.00002M - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.88M - 0.00150M 0.03M
Change to netincome 0.16M 0.00432M - - -
Capital expenditures 0.00000M 0.00096M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - 0.00115M 0.03M 0.02M
Stock based compensation - - - - -
Other non cash items - - -0.00115M -0.01030M 0.30M
Free cash flow - - 0.00002M -0.01252M -0.01863M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BLFE
BioLife Sciences Inc		 - -% 0.0001 - - 0.001 - 0.13 9.15
ISRG
Intuitive Surgical Inc		 0.39 0.10% 403.57 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 -0.25 0.13% 190.00 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -0.36 0.38% 95.30 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 3.50 2.43% 147.42 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

BioLife Sciences Inc. develops, licenses, and commercializes products and technologies for the healthcare, beauty, and food and beverage industries. It also offers orthomolecular products. The company is based in Henderson, Nevada.

BioLife Sciences Inc

2831 Saint Rose Parkway, Henderson, NV, United States, 89052

Key Executives

Name Title Year Born
Mr. Justin De Four Founder, CEO & Chairman 1990
Mr. Colton De Gooyer Director of Operations NA
Ms. Nika Jaksic COO & Director 1980
Ms. Nika Jaksic COO & Director 1981
Mr. Justin De Four Founder, CEO & Chairman 1991

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions